Personalised Medicine Market to See Remarkable Growth through 2021, Predicts Kelly Scientific in Its In-Demand Report Available at MarketPublishers.co27 Jun 2017 • by Natalie Aster
LONDON – The companion diagnostics and targeted therapeutics submarkets of the world’s personalised medicine market were evaluated at around USD 113 billion in the past year, and are expected to cross the value of USD 162 billion by 2021, exhibiting growth at an 8.74% CAGR. The overall personalized therapeutics market is also predicted to see remarkable upturn in the coming years.
Oncology still is an area with high unmet needs, which present great product revenue potential. Presently, oncology ranks the biggest world therapeutic area; it is expected to see further upturn at a rapid pace through 2021. The key driver in this area is the constantly rising cancer prevalence, which spurs the demand for more sensitive diagnostic and screening options. Targeted cancer therapeutics market has witnessed considerable sales growth in the recent years and is predicted to register robust growth through 2021.
Some of the prominent players in the world’s personalised medicine market include Pfizer, Roche, GSK, Sanofi, Amgen, Janssen, Novartis, AstraZeneca, BMS, amid others.
The in-demand topical study “Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2021- Strategic Analysis of Industry Trends, Technologies, Participants, and Environment” worked out by Kelly Scientific contains a detailed assessment of the personalised medicine market as well as targeted therapeutics and companion diagnostics sub-markets. It presents access to updated statistics for various market sectors, financial and strategic review of top players, relevant data on the major market growth restraints and drivers, identifies major challenges and opportunities. Besides, this study sheds light on the existing technologies and diagnostic tests, touches upon the current developments in the personalised medicine market and discusses pharmacogenomics revolution. The report covers the situation and trends across the leading country-wide markets, includes details on the historical background as well as provides access to an all-round future outlook through 2021 for the worlds personalised medicine market as well as targeted therapeutics and companion diagnostics sub-markets.
Many other research reports by this publisher are at hand in the Kelly Scientific catalogue at MarketPublishers.com.